Comparative Study of PD-L1 Expression in Different Sites of 
Non-small Cell Lung Cancer

Comparative Study of PD-L1 Expression in Different Sites of 
Non-small Cell Lung Cancer

Background and objective The expression of programmed cell death ligand 1 (PD-L1) as a biomarker for immunotherapy in non-small cell lung cancer (NSCLC) is routinely detected in clinical pathology department. However, the spatial heterogeneity of PD-L1 expression in intrapulmonary tumors and extrapu...

Full description

Bibliographic Details
Main Authors: Xiaozheng HUANG, Jianghua WU, Lixin ZHOU, Zhijie SONG, Wantong XU, Ling JIA, Xinting DIAO, Qi WU, Dongmei LIN
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2022-05-01
Series:Chinese Journal of Lung Cancer
Subjects:
lung neoplasms
programmed cell death ligand 1
heterogeneity
tumor proportion score
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.14

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.14

Similar Items